4-Nitrobenzaldehyd, min. 98 %, zur Synthese, 25 g, kunststoffverpackung.

Z-Aib-OH, 97%, 10g

5-[3,5-Bis(trifluoromethyl)phenyl]-3-(chloromethyl)-1,2,4-oxadiazole, 5g

2-(3-Bromophenyl)-6-fluoroquinoline-4-carboxylic acid, 98%, 250mg

2-((benzyl(ethyl)amino)methyl)aniline, 95.0%, 500mg

2-((4-chlorophenyl)sulfonyl)-3,3-dimethylthioprop-2-enenitrile, 95%, 10g

4-Bromo-2-(tert-butoxy)pyridine, 95.0%, 1g

1-(3-Fluorophenyl)-3-(3-((7-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-yl)amino)phenyl)urea, 97.0%, 50mg

4,4,4-Trifluoro-1-p-tolyl-butane-1,3-dione, 97.0%, 100g

2-Bromo-6-nitrotoluene, 98.0%, 5g

trans-4-Methoxycyclohexanamine hydrochloride, 97%, 1g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)benzonitrile, 98%, 1g

4-(4-Trifluoromethylphenoxy)piperidine hydrochloride, 95.0%, 1g